Advertisement

Topics

Sciele Pharma Company Profile

11:08 EDT 19th September 2017 | BioPortfolio

Sciele Pharma, Inc. (NASDAQ:SCRX), formerly known as First Horizon Pharmaceutical Corp., is a pharmaceutical company specializing in sales, marketing, and the development of branded prescription products focused on Cardiovascular/Metabolic and Women’s Health. The Company’s cardiovascular/metabolic products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina, and type 2 diabetes, and its Women’s Health products are designed to improve the health and well-being of women and their babies. Headquartered in Atlanta, Georgia, and founded in 1992, Sciele Pharma employs more than 700 people, including approximately 525 sales representatives. The Company’s success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform – an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity and Teamwork.

Location

Five Concourse Parkway
Suite 1800
Atlanta
Georgia
30328
United States of America

Contact

Phone: (800) 461-3696
Email: ir@sciele.com


News Articles [2297 Associated News Articles listed on BioPortfolio]

Fosun Pharma, Shanghai Pharma Bid for Arbor Pharma, Deal May Fetch $700 Million

  Life Sciences Jobs   ...

CEO of LEO Pharma on how they are driving collaborations

Précis: Gitte Aabo, CEO, LEO Pharma speaking at eyeforpharma Barcelona on what LEO Pharma are doing to drive collaborations and create more value for patients and healthcare.YouTube URL: ht...

Verona Pharma plc: Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference

May 23, 2017, LONDON - Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercialising innovative therapeutics for...

Verona Pharma plc: Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA

June 5, 2017, LONDON - Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics f...

#jobs #lifescience Assistant Controller – Pharma

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Assistant Controller – Pharma .NJ-Fort Lee, RESPONSIBILITIES: Kforce...

#jobs #lifescience 4D Pharma PLC: Senior Immunologist II (Team Leader) – Aberdeen

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: 4D Pharma PLC: Senior Immunologist II (Team Leader) – Aberdeen . Compet...

Verona Pharma plc: Verona Pharma to Announce Interim Results for Six Months Ended June 30, 2017 and Provide Clinical Development Update

LONDON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

Horizon Pharma Reports 2Q Loss of $209.5M

NewsHorizon Pharma Inc. reported a second-quarter loss of $209.5 million on Monday after reporting a profit in the same period a year earlier.Contributed Author: 

Drugs and Medications [242 Associated Drugs and Medications listed on BioPortfolio]

Cedax [Sciele Pharma, Inc.]

CEDAX (ceftibuten capsules) and (ceftibuten for oral suspension)

Prenate essential [Sciele Pharma, Inc.]

Prenate Essential™ Rx prenatal vitamin & DHA

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

PubMed Articles [31 Associated PubMed Articles listed on BioPortfolio]

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Clinical Trials Series - Large Pharma.

AI-powered drug discovery captures pharma interest.

Clinical Trials [73 Associated Clinical Trials listed on BioPortfolio]

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier 400...

To Demonstrate the Relative Bioavailability of Cilostazol 50 mg Tablets Under Fasting Conditions

To demonstrate the relative bioavailability of Cilostazol 50 mg tablets under fasting conditions.

Companies [717 Associated Companies listed on BioPortfolio]

Sciele Pharma, Inc.

Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) today announced that its U.S.-based group company, Sciele Pharma, Inc. (hereaf...

Sciele Pharma

Sciele Pharma, Inc. (NASDAQ:SCRX), formerly known as First Horizon Pharmaceutical Corp., is a pharmaceutical company specializing in sales, marketing, and the development of branded prescription produ...

Sciele Pharma, Inc., a Shionogi Company

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

More Information about "Sciele Pharma" on BioPortfolio

We have published hundreds of Sciele Pharma news stories on BioPortfolio along with dozens of Sciele Pharma Clinical Trials and PubMed Articles about Sciele Pharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sciele Pharma Companies in our database. You can also find out about relevant Sciele Pharma Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Corporate Database Quicklinks



Searches Linking to this Company Record